| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4277511 | Aesthetic Surgery Journal | 2009 | 7 Pages |
Abstract
Multiple cycles with fixed or variable dosing of BoNTA-ABO are well tolerated. There was no evidence of cumulative safety issues because the incidence of AE remained relatively constant or decreased over repeated treatment cycles.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Joel L. MD, Joel MD, Sue Ellen MD, Xiaoming Lin, for the Reloxin Investigational Group for the Reloxin Investigational Group,